Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

New health startups dealing with increased FDA scrutiny

As more health-related tech startups emerge in Silicon Valley, the FDA and other government agencies are stepping up their presence in the region like never before.

Study: Increased spending on social services improves health

States that increased spending on public health and social services programs between 2000 and 2009 saw significant improvement in health outcomes in areas such as adult obesity and asthma.

Tour 11 of the country's best healthcare workplaces

With the merging of many healthcare companies, one might wonder which ones treat their employees the best.

Joint Commission reverses course, OKs secure clinician texting

The commission's update allows for clinician texting and messaging for “care, treatment, and services…across all accreditation programs.”

States improve quality, reduce costs via reform

States that have implemented health reform options have reduced costs while also maintaining or even improving the quality of care.

NY med schools: clerkships are scarce because of offshore competition

Medical school students in New York are having trouble finding available clinical clerkships because for-profit, offshore medical schools are paying for slots.

Aetna CEO calls exchanges ‘good investment,’ raises earnings forecast

Aetna's CEO says the insurer won’t lose money on its health insurance marketplace business this year.

Proposed change to Medicare Part B finding little support in Congress

Pilot program would reduce the 6 percent add-on to the average sales price to 2.5 percent plus a flat fee of $16.80 per drug per day

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.